美国临床生化科学院和国际临床化学联合会心脏损伤标志物标准化委员会检验医学实践指南:急性冠状动脉综合征生物标志物检测问题
出处
《临床检验杂志》
CAS
CSCD
北大核心
2009年第5期I0022-I0024,共3页
Chinese Journal of Clinical Laboratory Science
参考文献23
-
1Wu AHB, Apple F S, Gibler W B, et al. National academy of clinical biochemistry standards of laboratory practice: recommendations for use of cardiac markers in coronary artery diseases[J]. Clin Chem, 1999, 45:1104-1121.
-
2Panteghini M, Gerhardt W, Apple F S, et al. Quality specifications for cardiac troponin assays[ J]. Clin Chem Lab Med, 2001,39:174- 178.
-
3National Institute of Standards and Technology. Certificate of analysis. Standard reference material 2921 : human cardiac troponin complex. Gaithersburg, MD: NIST, 2004.
-
4Christenson R H, Duh S H, Apple F S, et al. Standardization of cardiac troponin I assays: round robin performance of ten candidate reference materials [ J ]. Clin Chem, 2001,47 : 431-437.
-
5Christenson R H, Duh S H, Apple F S, et al. Toward standardization of cardiac troponin I measurements. Part II : Assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays[ J]. Clin Chem, 2006, 52:1685-1692.
-
6Jaffe A S, Babuin L, Apple F S. Biomarkers in acute coronary disease: the present and the future[J]. J Am Coil Cardiol, 2006, 48: 1-11.
-
7Panteghini M. Standardization of cardiac troponin I measurements: The way forward [ J ] ? Clin Chem, 2005, 51 : 1594-1597.
-
8Clinical and Laboratory Standards Institute. EP17-A. Protocols for determination of limits of detection and limits of quantitation; Approved guideline[ S]. 2004.
-
9Clinical and Laboratory Standards Institute. EPS-A2. Evaluation of precision performance of quantitative measurement methods ; approved guideline, 2nd ed[S]. 2004.
-
10Novis D A, Jones B A, Dale J C, et al. Biochemical markers of myocardial injury test turnaround time : a College of American Pathologists Q-probe Study[ J]. Arch Path Lab Med, 2004, 128:158-164.
-
1张麟,李江,田亚平,鄢盛恺.美国临床生化科学院和国际临床化学联合会心脏损伤标志物标准化委员会检验医学实践指南:心力衰竭生物标志物检测问题[J].临床检验杂志,2009,27(5). 被引量:1
-
2Robert H. Christenson, Ph. D,罗丹(翻译),魏有仁(审校),鄢盛恺(审校).美国临床生化科学院关于在急性冠状动脉综合征和心力衰竭中应用生物标志物的检验医学实践指南[J].临床检验杂志,2009,27(5).
-
3易建军,周仕钧,廖渝.吸烟对2型糖尿病患者糖代谢的影响[J].医学临床研究,2003,20(12):912-914. 被引量:2
-
4杨振华.国外临床化学某些进展[J].中华医学检验杂志,1995,18(6):333-335. 被引量:1
-
5潘柏申.美国临床生化科学院关于冠心病时心肌标志物的应用建议[J].上海医学检验杂志,2000,15(1):5-7. 被引量:40
-
6王连喜.冠状动脉疾病和心力衰竭时心脏标志物的临床检测应用建议[J].中国医药指南,2016,14(8):297-298.
-
7翟春苗.联合检测糖化血红蛋白和果糖胺对诊断糖尿病的临床价值分析[J].当代医药论丛,2015,13(21):35-36. 被引量:1
-
8彭海林,陈国顺,石建荣,赵丹,王娟.艾滋病病毒检测问题的探讨[J].实用医技杂志,2008,15(26):3632-3633.
-
9陈屮,金勋,鄢盛恺,魏有仁.美国临床生化科学院检验医学实践指南:心脏标志物检测在心力衰竭中的临床应用[J].临床检验杂志,2009,27(5). 被引量:2
-
10王晶,阮玉华,邢辉.HIV耐药突变对后续抗病毒治疗效果影响的研究进展[J].中华微生物学和免疫学杂志,2013,33(6):470-473. 被引量:2